Healthcare Sales & Marketing Network News: Arch Therapeutics

Searching News Database: Arch Therapeutics

HSMN NewsFeed - 15 May 2017
Formation Biologics Announces Dosing of First Patient in a Phase I/IIa Trial of AVID100, Closing of Series B Financing, and Appointment of Dr. Anthony Tolcher to its Board of Directors
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 20 Aug 2015
Arch Therapeutics Appoints James Sulat to Board of Directors
Devices Surgery Personnel

HSMN NewsFeed - 30 Jul 2013
Arch Therapeutics Reports on Current Activities
Devices Surgery

HSMN NewsFeed - 8 Jul 2013
Arch Therapeutics Appoints Senior Management Team Members
Devices Surgery Personnel

HSMN NewsFeed - 2 Jul 2013
Arch Therapeutics Introduces Experienced Directors and Executive Leadership
Devices Surgery Personnel

HSMN NewsFeed - 28 Nov 2012
Curis Announces Worldwide In-Licensing of IAP Inhibitor GDC-0917 From Genentech
Biopharmaceuticals Oncology Licensing

HSMN NewsFeed - 28 Apr 2008
Arch Therapeutics Licenses Groundbreaking Intellectual Property on Hemostasis
Biopharmaceuticals Surgery Licensing

HSMN NewsFeed - 25 Mar 2008
Micromet Establishes New Scientific Advisory Board for Its BiTE Antibody Technology with Leading Experts in the Fields of Oncology, Immunotherapy and Drug Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Mar 2008
Genta Announces Licensing Agreement for Worldwide Development and Commercialization of a Leading Oral Taxane, Tesetaxel
Biopharmaceuticals Licensing Oncology

Return to NewsFeed

Additional items found! 1

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 1 additional stories matching:
Arch Therapeutics
(Password required)

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.